Dana Farber/ Brigham & Women's Cancer Center

Boston, Massachusetts 02215

0 studies enrolling now · 1 studies all time

What they study most

Acute Myeloid Leukemia

Studies at this site

• A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AML — Completed